» Articles » PMID: 37596501

Context-dependent TGFβ Family Signalling in Cell Fate Regulation

Overview
Date 2023 Aug 18
PMID 37596501
Authors
Affiliations
Soon will be listed here.
Abstract

The transforming growth factor-β (TGFβ) family are a large group of evolutionarily conserved cytokines whose signalling modulates cell fate decision-making across varying cellular contexts at different stages of life. Here we discuss new findings in early embryos that reveal how, in contrast to our original understanding of morphogen interpretation, robust cell fate specification can originate from a noisy combination of signalling inputs and a broad range of signalling levels. We compare this evidence with novel findings on the roles of TGFβ family signalling in tissue maintenance and homeostasis during juvenile and adult life, spanning the skeletal, haemopoietic and immune systems. From these comparisons, it emerges that in contrast to robust developing systems, relatively small perturbations in TGFβ family signalling have detrimental effects at later stages in life, leading to aberrant cell fate specification and disease, for example in cancer or congenital disorders. Finally, we highlight novel strategies to target and amend dysfunction in signalling and discuss how gleaning knowledge from different fields of biology can help in the development of therapeutics for aberrant TGFβ family signalling in disease.

Citing Articles

Anti-TGF-β/PD-L1 bispecific antibody synergizes with radiotherapy to enhance antitumor immunity and mitigate radiation-induced pulmonary fibrosis.

Wu Y, Yan Y, Guo Y, Niu M, Zhou B, Zhang J J Hematol Oncol. 2025; 18(1):24.

PMID: 40038780 PMC: 11881499. DOI: 10.1186/s13045-025-01678-2.


TGFβ signaling sensitizes MEKi-resistant human melanoma to targeted therapy-induced apoptosis.

Loos B, Salas-Bastos A, Nordin A, Debbache J, Stierli S, Cheng P Cell Death Dis. 2024; 15(12):925.

PMID: 39709491 PMC: 11663225. DOI: 10.1038/s41419-024-07305-1.


TGF-β signaling-related signature for predicting prognosis and therapeutic response in lower-grade glioma.

Yan J, Zhou X, Yang H Transl Cancer Res. 2024; 13(9):4985-5002.

PMID: 39430851 PMC: 11483406. DOI: 10.21037/tcr-24-144.


The balance between helper T 17 and regulatory T cells in osteoimmunology and relevant research progress on bone tissue engineering.

Zhu S, Zhou J, Xie Z Immun Inflamm Dis. 2024; 12(9):e70011.

PMID: 39264247 PMC: 11391570. DOI: 10.1002/iid3.70011.


The Role of the MiR-181 Family in Hepatocellular Carcinoma.

Chen J, Liu K, Vadas M, Gamble J, McCaughan G Cells. 2024; 13(15.

PMID: 39120319 PMC: 11311592. DOI: 10.3390/cells13151289.


References
1.
Adamska M, Degnan S, Green K, Adamski M, Craigie A, Larroux C . Wnt and TGF-beta expression in the sponge Amphimedon queenslandica and the origin of metazoan embryonic patterning. PLoS One. 2007; 2(10):e1031. PMC: 2000352. DOI: 10.1371/journal.pone.0001031. View

2.
Huminiecki L, Goldovsky L, Freilich S, Moustakas A, Ouzounis C, Heldin C . Emergence, development and diversification of the TGF-beta signalling pathway within the animal kingdom. BMC Evol Biol. 2009; 9:28. PMC: 2657120. DOI: 10.1186/1471-2148-9-28. View

3.
David C, Massague J . Contextual determinants of TGFβ action in development, immunity and cancer. Nat Rev Mol Cell Biol. 2018; 19(7):419-435. PMC: 7457231. DOI: 10.1038/s41580-018-0007-0. View

4.
Hinck A, Mueller T, Springer T . Structural Biology and Evolution of the TGF-β Family. Cold Spring Harb Perspect Biol. 2016; 8(12). PMC: 5131774. DOI: 10.1101/cshperspect.a022103. View

5.
Tajer B, Mullins M . Heterodimers reign in the embryo. Elife. 2017; 6. PMC: 5745075. DOI: 10.7554/eLife.33682. View